We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPNT icon
12126
SiriusPoint
SPNT
$2.76B
$151K ﹤0.01%
+18,577
New +$164K
SYRE icon
12127
CALL
Spyre Therapeutics
SYRE
$9.14B
$151K ﹤0.01%
1,268
+860
+211% +$136K
WSR
12128
CALL
DELISTED
Whitestone REIT
WSR
$151K ﹤0.01%
14,900
-22,500
-60% -$219K
AMBR
12129
PUT
Amber International Holding Ltd
AMBR
$124M
$151K ﹤0.01%
3,280
+320
+11% +$19.7K
PVLA
12130
CALL
Palvella Therapeutics
PVLA
$2.25B
$151K ﹤0.01%
500
-635
-56% -$203K
KVSA
12131
PUT
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$151K ﹤0.01%
+15,600
New +$154K
AMPE
12132
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$151K ﹤0.01%
884
-237
-21% -$88.4K
APRE icon
12133
PUT
Aprea Therapeutics
APRE
$8.42M
$150K ﹤0.01%
2,605
-2,720
-51% -$240K
AYTU icon
12134
CALL
AYTU BioPharma
AYTU
$25.5M
$150K ﹤0.01%
5,565
+3,661
+192% +$158K
CPRX
12135
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$150K ﹤0.01%
22,200
+11,700
+111% +$76.9K
MNSO icon
12136
PUT
MINISO
MNSO
$3.52B
$150K ﹤0.01%
14,500
+700
+5% +$9.73K
NRDY icon
12137
PUT
Nerdy
NRDY
$90.4M
$150K ﹤0.01%
33,300
-35,400
-52% -$253K
OWLT icon
12138
CALL
Owlet
OWLT
$195M
$150K ﹤0.01%
4,007
-1,729
-30% -$92.3K
RVP icon
12139
Retractable Technologies
RVP
$20.7M
$150K ﹤0.01%
21,664
+9,110
+73% +$78.6K
GMDA
12140
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$150K ﹤0.01%
59,085
+13,010
+28% +$42.9K
CD
12141
CALL
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$150K ﹤0.01%
22,800
-85,600
-79% -$733K
INFI
12142
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$150K ﹤0.01%
66,700
-54,500
-45% -$137K
ACHV icon
12143
Achieve Life Sciences
ACHV
$779M
$149K ﹤0.01%
+19,207
New +$151K
BCDA icon
12144
CALL
BioCardia
BCDA
$14.7M
$149K ﹤0.01%
5,113
+3,193
+166% +$117K
GRFS
12145
PUT
Grifois
GRFS
$5.29B
$149K ﹤0.01%
13,300
-300
-2% -$3.68K
LQDA icon
12146
CALL
Liquidia Corp
LQDA
$6.66B
$149K ﹤0.01%
30,600
+10,500
+52% +$41.9K
MXC icon
12147
Mexco Energy
MXC
$19M
$149K ﹤0.01%
+15,905
New +$171K
RFIL icon
12148
PUT
RF Industries
RFIL
$148M
$149K ﹤0.01%
+18,600
New +$139K
SNTI icon
12149
Senti Biosciences Holdings
SNTI
$14M
$149K ﹤0.01%
+1,507
New +$150K
WTTR icon
12150
CALL
Select Water Solutions
WTTR
$2.69B
$149K ﹤0.01%
23,900
-1,100
-4% -$6.84K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.